nach oben

Child's Nervous System

Erschienen in:

01.08.2005 | Special Annual Issue

Intracavitary therapeutic options in the management of cystic craniopharyngioma

verfasst von: Adrián Cáceres

Erschienen in: Child's Nervous System | Ausgabe 8-9/2005

Einloggen, um Zugang zu erhalten

Abstract

Background

Craniopharyngioma remains an entity of controversial management due to its critical anatomical relationships and its well-known recurrence tendency. Total resection, although desirable, is not always accomplished, and it is associated with potentially permanent endocrinological and visual deficits. Consequently, this situation has led to the development of new management strategies seeking lesser morbidity. Because a high percentage of these lesions are cystic, bleomycin and radioactive-emitting sources have been postulated as new therapeutic options with promising results.

Discussion

The information known to date regarding these substances is summarized and we perform a retrospective review of the clinical trials conducted over the past 30 years with special emphasis on outcome, morbidity, and mortality. Two cases from our institution are presented as examples of multimodality management.

Conclusion

Overall, these newer options stand out as valid alternatives in the controversial management of these challenging tumors.

Adamson TE, Wiestler OD, Kleihues P, Yasargil MG (1990) Correlation of clinical and pathological features in surgically treated craniopharyngiomas. J Neurosurg 73(1):12–17

Alen JF, Boto GR, Lagares A, de la Lama A, Gomez PA, Lobato RD (2002) Intratumoural bleomycin as a treatment for recurrent cystic craniopharyngioma. Case report and review of the literature. Neurocirugia (Astur) 13(6):479–485

Anderson DR, Trobe JD, Taren JA, Gebarski SS (1989) Visual outcome in cystic craniopharyngiomas treated with intracavitary phosphorus-32. Ophthalmology 96(12):1786–1792

Backlund EO (1989) Colloidal radioisotopes as part of a multi-modality treatment of craniopharyngiomas. J Neurosurg Sci 33(1):95–97

Backlund EO, Axelsson B, Bergstrand CG, Eriksson AL, Noren G, Ribbesjo E, Rahn T, Schnell PO, Tallstedt L, Saaf M et al (1989) Treatment of craniopharyngiomas—the stereotactic approach in a ten to twenty-three years’ perspective. I. Surgical, radiological and ophthalmological aspects. Acta Neurochir (Wien) 99(1–2):11–19

Bin-Abbas B, Mawlawi H, Sakati N, Khafaja Y, Chaudhary MA, Al-Ashwal A (2001) Endocrine sequelae of childhood craniopharyngioma. J Pediatr Endocrinol Metab 14(7):869–874

Blackburn TP, Doughty D, Plowman PN (1999) Stereotactic intracavitary therapy of recurrent cystic craniopharyngioma by instillation of 90yttrium. Br J Neurosurg 13(4):359–365

Bosch DA, Kindmorsh TH, Larsson ST, Backlund EO (1980) Intraneoplastic administration of Bleomycin in intracerebral gliomas, a pilot study. Acta Neurochir Suppl 30:441–444

Broggi G, Franzini A (1996) Bleomycin for cystic craniopharyngioma. J Neurosurg 84(6):1080–1081

10.

Broggi G, Franzini A, Cajola L, Pluchino F (1994) Cell kinetic investigations in craniopharyngioma: preliminary results and considerations. Pediatr Neurosurg 21(Suppl 1):21–23

11.

Broggi G, Giorgi C, Franzini A, Servello D, Solero CL (1989) Preliminary results of intracavitary treatment of craniopharyngioma with bleomycin. J Neurosurg Sci 33(1):145–148

12.

Buckell M, Crompton MR, Robertson MC, Barnes GK (1970) Lactate dehydrogenase in cerebral cyst fluids; total activity and isoenzyme distributions as an index of malignancy. J Neurosurg 32(5):545–552

13.

Caldarelli M, Di Rocco C, Papacci F, Colosimo C Jr (1998) Management of recurrent craniopharyngioma. Acta Neurochir (Wien) 140(5):447–454

14.

Cavalheiro S, Sparapani FV, Franco JO, da Silva MC, Braga FM (1996) Use of bleomycin in intratumoral chemotherapy for cystic craniopharyngioma. Case report. J Neurosurg 84(1):124–126

15.

Dorr RT, Von-Hoff DD (1994) Drug monographs. In: Cancer chemotherapy handbook, 2nd edn. Appleton and Lange, Norwalk, CT, pp 227–236

16.

Fahlbusch R, Honegger J, Paulus W, Huk W, Buchfelder M (1999) Surgical treatment of craniopharyngiomas: experience with 168 patients. J Neurosurg 90(2):237–250

17.

Fisher PG, Jenab J, Goldthwaite PT, Tihan T, Wharam MD, Foer DR, Burger PC (1998) Outcomes and failure patterns in childhood craniopharyngiomas. Childs Nerv Syst 14:558–563

18.

Frank F, Fabrizi AP, Frank G, Fioravanti A (1995) Stereotactic management of craniopharyngiomas. Stereotact Funct Neurosurg 65(1–4):176–183

19.

Greenberg SB, Magram G (2000) Magnetic resonance cystography with gadopenetate dimeglumine of a cystic craniopharyngioma in a child—a technical note. Pediatr Radiol 30(2):85–86

20.

Guevara JA, Bunge HJ, Heinrich JJ, Weller G, Villasante A, Chinela AB (1988) Cystic craniopharyngioma treated by 90yttrium silicate colloid. Acta Neurochir Suppl (Wien) 42:109–112

21.

Hader WJ, Steinbok P, Hukin J, Fryer C (2000) Intratumoral therapy with bleomycin for cystic craniopharyngiomas in children. Pediatr Neurosurg 33(4):211–218

22.

Haisa T, Ueki K, Yoshida S (1994) Toxic effects of bleomycin on the hypothalamus following its administration into a cystic craniopharyngioma. Br J Neurosurg 8(6):747–750

23.

Hall WA, Liu H, Truwit CL (2003) Intraoperative MR-guided instillation of phosphorus-32 for cystic craniopharyngiomas: case report. Technol Cancer Res Treat 2(1):19–24

24.

Hasegawa T, Kondziolka D, Hadjipanayis CG, Lunsford LD (2004) Management of cystic craniopharyngiomas with phosphorus-32 intracavitary irradiation. Neurosurgery 54(4):813–820

25.

Hernandez J, Morel C, Gonzalez A, Garcia S, Hernandez M, Zarate A (2002) Uso de la bleomicina mediante un reservorio local en pacientes con craneofaringiomas quísticos. Med Int Mex 18(6):273–277

26.

Hetelekidis S, Barnes PD, Tao ML, Fischer EG, Schneider L, Scott RM, Tarbell NJ (1993) 20-year experience in childhood craniopharyngioma. Int J Radiat Oncol Biol Phys 27(2):189–195

27.

Hoffman HJ, De Silva M, Humphreys RP, Drake JM, Smith ML, Blaser SI (1992) Aggressive surgical management of craniopharyngiomas in children. J Neurosurg 76(1):47–52

28.

Huk WJ, Mahlstedt J (1983) Intracystic radiotherapy (90Y) of craniopharyngiomas: CT-guided stereotaxic implantation of indwelling drainage system. Am J Neuroradiol 4(3):803–806

29.

Ishii K, Sugita K, Kobayashi H, Kamida T, Fujiki M, Izumi T, Mori T (2004) Intracranial ectopic recurrence of craniopharyngioma after Ommaya reservoir implantation. Pediatr Neurosurg 40(5):230–233

30.

Jiang R, Liu Z, Zhu C (2002) Preliminary exploration of the clinical effect of bleomycin on craniopharyngiomas. Stereotact Funct Neurosurg 78(2):84–94

31.

Julow J, Lanyi F, Hajda M, Simkovics M, Arany I, Toth S, Pasztor E (1985) The radiotherapy of cystic craniopharyngioma with intracystic installation of 90Y silicate colloid. Acta Neurochir (Wien) 74(3–4):94–99

32.

Kalapurakal JA, Goldman S, Hsieh YC, Tomita T, Marymont MH (2003) Clinical outcome in children with craniopharyngioma treated with primary surgery and radiotherapy deferred until relapse. Med Pediatr Oncol 40(4):214–218

33.

Kobayashi T, Kageyama N, Ohara K (1981) Internal irradiation for cystic craniopharyngioma. J Neurosurg 55(6):896–903

34.

Kodama T, Matsukado Y, Uemura S (1981) Intracapsular irradiation therapy of craniopharyngiomas with radioactive gold: indication and follow-up results. Neurol Med-Chir (Tokyo) 21(1):49–58

35.

Kubo O, Takakura K, Miki Y, Okino T, Kitamura K (1974) Intracystic therapy of bleomycin for craniopharyngioma—effect of bleomycin for cultured craniopharyngioma cells and intracystic concentration of bleomycin (author’s transl). No Shinkei Geka 2(10):683–688

36.

Lange M, Kirsch CM, Steude U, Oeckler R (1995) Intracavitary treatment of intrasellar cystic craniopharyngiomas with 90-yttrium by trans-sphenoidal approach—a technical note. Acta Neurochir (Wien) 135(3–4):206–209

37.

Leksell L (1951) The stereotaxic method and radiosurgery of the brain. Acta Chir Scand 102(4):316–319

38.

Lunsford LD, Pollock BE, Kondziolka DS, Levine G, Flickinger JC (1994) Stereotactic options in the management of craniopharyngioma. Pediatr Neurosurg 21(Suppl 1):90–97

39.

Merchant TE, Kiehna EN, Sanford RA, Mulhern RK, Thompson SJ, Wilson MW, Lustig RH, Kun LE (2002) Craniopharyngioma: the St. Jude Children’s Research Hospital experience 1984–2001. Int J Radiat Oncol Biol Phys 53(3):533–542

40.

Morantz RA, Kimler BF, Vats TS, Hendrson SD (1983) Bleomycin and brain tumors, a review. J Neuroncol 1:249–255

41.

Mottolese C, Stan H, Hermier M, Berlier P, Convert J, Frappaz D, Lapras C (2001) Intracystic chemotherapy with bleomycin in the treatment of craniopharyngiomas. Childs Nerv Syst 17(12):724–730

42.

Musolino A, Munari C, Blond S, Betti O, Lajat Y, Schaub C, Askienazy S, Chodkiewicz JP (1985) Stereotaxic treatment of expanding cysts in craniopharyngiomas by endocavitary beta-irradiation (Re-186; Au-198; Y-90). Neurochirurgie 31(3):169–178

43.

Nakazawa S, Ohwaki K, Shimura T, Itoh Y, Yajima K (1981) A new treatment of malignant brain tumor—1. Local injection of bleomycin. No Shinkei Geka 9(13):1487–1493

44.

Netzeband G, Sturm V, Georgi P (1984) Results of stereotactic intracavitary irradiation of cystic craniopharyngiomas. Comparison of the effects of Yttrium-90 and Rhenium-186. Acta Neurochir Suppl 33:341–344

45.

Pan DH, Lee LS, Huang CI, Wong TT (1990) Stereotactic internal irradiation for cystic craniopharyngiomas: a 6-year experience. Stereotact Funct Neurosurg 54–55:525–530

46.

Park DH, Park JY, Kim JH, Chung YG, Lee HK, Lee KC, Suh JK (2002) Outcome of postoperative intratumoral bleomycin injection for cystic craniopharyngioma. J Korean Med Sci 17(2):254–259

47.

Perry M (2001) The chemotherapy source book. Lippincott Williams & Wilkins, Philadelphia, pp 237–239

48.

Pollack IF, Lunsford LD, Slamovits TL, Gumerman LW, Levine G, Robinson AG (1988) Stereotaxic intracavitary irradiation for cystic craniopharyngiomas. J Neurosurg 68(2):227–233

49.

Pollock BE, Lunsford LD, Kondziolka D, Levine G, Flickinger JC (1995) Phosphorus-32 intracavitary irradiation of cystic craniopharyngiomas: current technique and long-term results. Int J Radiat Oncol Biol Phys 33(2):437–446

50.

Rajan B, Ashley S, Gorman C, Jose CC, Horwich A, Bloom HJ, Marsh H, Brada M (1993) Craniopharyngioma—a long-term results following limited surgery and radiotherapy. Radiother Oncol 26(1):1–10

51.

Reda WA, Hay AA, Ganz JC (2002) A planned combined stereotactic approach for cystic intracranial tumors. Report of two cases. J Neurosurg 97(5 Suppl):610–612

52.

Saaf M, Thoren M, Bergstrand CG, Noren G, Rahn T, Tallstedt L, Backlund EO(1989) Treatment of craniopharyngiomas—the stereotactic approach in a ten to twenty-three years’ perspective. II. Psychosocial situation and pituitary function. Acta Neurochir (Wien) 99(3–4):97–103

53.

Sagoh M, Murakami H, Hirose Y, Mayanagi K (1997) Occlusive cerebrovasculopathy after internal radiation and bleomycin therapy for craniopharyngioma—case report. Neurol Med-Chir (Tokyo) 37(12):920–923

54.

Savas A, Arasil E, Batay F, Selcuki M, Kanpolat Y (1999) Intracavitary chemotherapy of polycystic craniopharyngioma with bleomycin. Acta Neurochir (Wien) 141(5):547–548

55.

Savas A, Erdem A, Tun K, Kanpolat Y (2000) Fatal toxic effect of bleomycin on brain tissue after intracystic chemotherapy for a craniopharyngioma: case report. Neurosurgery 46(1):213–216

56.

Schefter JK, Allen G, Cmelak AJ, Johnson M, Toms S, Duggan D, Blevins LS (2002) The utility of external beam radiation and intracystic 32P radiation in the treatment of craniopharyngiomas. J Neurooncol 56(1):69–78

57.

Schulz-Ertner D, Frank C, Herfarth KK, Rhein B, Wannenmacher M, Debus J (2002) Fractionated stereotactic radiotherapy for craniopharyngiomas. Int J Radiat Oncol Biol Phys 54(4):1114–1120

58.

Scott RM, Hetelekidis S, Barnes PD, Goumnerova L, Tarbell NJ (1994) Surgery, radiation, and combination therapy in the treatment of childhood craniopharyngioma—a 20-year experience. Pediatr Neurosurg 21(Suppl 1):75–81

59.

Shapiro B, Fig LM, Gross MD (1999) Intracavitary therapy of craniopharyngiomas. Q J Nucl Med 43(4):367–374

60.

Strauss L, Sturm V, Georgi P, Schlegel W, Ostertag H, Clorius JH, van Kaick G (1982) Radioisotope therapy of cystic craniopharyngomas. Int J Radiat Oncol Biol Phys 8(9):1581–1585

61.

Sturm V, Rommel T, Strauss L (1981) Preliminary results of intracavitary irradiation of cystic craniopharyngiomas by means of stereotactically applied yttrium-90. In: Schiefer W, Klinger M, Brock M (eds) Advances in neurosurgery 9. Springer, Berlin Heidelberg New York, pp 401–404

62.

Sweet WH (1994) History of surgery for craniopharyngiomas. Pediatr Neurosurg 21(Suppl 1):28–38

63.

Szeifert GT, Julow J, Slowik F, Balint K, Lanyi F, Pasztor E (1990) Pathological changes in cystic craniopharyngiomas following intracavital 90yttrium treatment. Acta Neurochir (Wien) 102(1–2):14–18

64.

Szikla G, Musolino A, Miyahara S (1984) Colloidal rhenium-186 endocavitary irradiation of cystic craniopharyngiomas and active glioma cysts. Long term results, side effects and clinical dosimetry. Acta Neurochir Suppl 33:331–339

65.

Takahashi H, Nakazawa S, Shimura T (1985) Evaluation of postoperative intratumoral injection of bleomycin for craniopharyngioma in children. J Neurosurg 62(1):120–127

66.

Takeuchi K (1975) A clinical trial of intravenous bleomycin in the treatment of brain tumors. Int J Clin Pharmacol Biopharm 12(4):419–426

67.

Takeuchi K (1976) Effect of bleomycin on brain tumors. In: Carter SK, Ichikawa T, Mathe G et al (eds) Fundamental and clinical studies of bleomycin, vol 19. Gann monograph on cancer research. Japan Scientific Societies Press, Tokyo, pp 117–132

68.

Tomita T (1988) Management of craniopharyngiomas in children. Pediatr Neurosci 14(4):204–211

69.

Umezawa H, Maeda K, Takeuchi T, Okami Y (1966) New antibiotics, bleomycin A and B. J Antibiot (Tokyo) 19(5):200–209

70.

Van den Berge JH, Blaauw G, Breeman WA, Rahmy A, Wijngaarde R (1992) Intracavitary brachytherapy of cystic craniopharyngiomas. J Neurosurg 77(4):545–550

71.

Vitaz TW, Hushek S, Shields CB, Moriarty T (2001) Changes in cyst volume following intraoperative MRI-guided Ommaya reservoir placement for cystic craniopharyngioma. Pediatr Neurosurg 35(5):230–234

72.

Voges J, Sturm V, Lehrke R, Treuer H, Gauss C, Berthold F (1997) Cystic craniopharyngioma: long-term results after intracavitary irradiation with stereotactically applied colloidal beta-emitting radioactive sources. Neurosurgery 40(2):263–269

73.

Wycis HT, Robbins R, Spiegel M, Meszaros J, Spiegel EA (1954) Studies in stereoencephalotomy. III. Treatment of a cystic craniopharyngioma by injection of radioactive P32. Confin Neurol 14(4):193–202

74.

Young HF, Fu YS, Fratkin MJ (1976) Organ culture of craniopharyngioma and its cellular effects induced by colloidal chromic phosphate. J Neuropathol Exp Neurol 35(4):404–412

75.

Zanon N (1998) Craniopharyngiomas: intratumoral chemotherapy with bleomycin in children and adolescents. Thesis, Sao Paulo 1997. Arq Neuropsiquiatria 56(4):859–864

Titel: Intracavitary therapeutic options in the management of cystic craniopharyngioma
verfasst von: Adrián Cáceres
Publikationsdatum: 01.08.2005
Verlag: Springer-Verlag
Erschienen in: Child's Nervous System / Ausgabe 8-9/2005
Print ISSN: 0256-7040
Elektronische ISSN: 1433-0350
DOI: https://doi.org/10.1007/s00381-005-1227-0

Neu im Fachgebiet Chirurgie

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

23.04.2024 Ablationstherapie Nachrichten

Nach der Katheterablation von Vorhofflimmern kommt es bei etwa einem Drittel der Patienten zu Rezidiven, meist binnen eines Jahres. Wie sich spätere Rückfälle auf die Erfolgschancen einer erneuten Ablation auswirken, haben Schweizer Kardiologen erforscht.

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 Appendizitis Nachrichten

Schmerzen im Unterbauch, aber sonst nicht viel, was auf eine Appendizitis hindeutete: Ein junger Mann hatte Glück, dass trotzdem eine Laparoskopie mit Appendektomie durchgeführt und der Wurmfortsatz histologisch untersucht wurde.

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

23.04.2024 Operationsvorbereitung Nachrichten

Derzeit wird empfohlen, eine Therapie mit GLP-1-Rezeptoragonisten präoperativ zu unterbrechen. Eine neue Studie nährt jedoch Zweifel an der Notwendigkeit der Maßnahme.

Ureterstriktur: Innovative OP-Technik bewährt sich

19.04.2024 EAU 2024 Kongressbericht

Die Ureterstriktur ist eine relativ seltene Komplikation, trotzdem bedarf sie einer differenzierten Versorgung. In komplexen Fällen wird dies durch die roboterassistierte OP-Technik gewährleistet. Erste Resultate ermutigen.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Aktuelle BDC Leitlinien-Webinare

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare

CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare

CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske

Dr. med. Benjamin Meyknecht

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare

CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric

Springer Medizin

Abstract

Background

Discussion

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 8-9/2005

Individualized treatment of craniopharyngioma in children: ways and means

Application of endoscopy to the surgical management of craniopharyngiomas

Endocrine manifestations of craniopharyngioma

Fronto-basal interhemispheric approach for craniopharyngiomas extending outside the suprasellar cistern

33rd Annual Meeting of the International Society for Pediatric Neurosurgery, Vancouver, Canada, 11-15 September 2005

Craniopharyngioma in childhood: our evidence-based approach to management

Update Chirurgie